330 related articles for article (PubMed ID: 25155654)
1. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
[TBL] [Abstract][Full Text] [Related]
2. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
[TBL] [Abstract][Full Text] [Related]
3. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
[TBL] [Abstract][Full Text] [Related]
4. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.
Rizvi B; Narkhede A; Last BS; Budge M; Tosto G; Manly JJ; Schupf N; Mayeux R; Brickman AM
Neurobiol Aging; 2018 Apr; 64():25-32. PubMed ID: 29328963
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
7. The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.
Tosto G; Zimmerman ME; Hamilton JL; Carmichael OT; Brickman AM;
Alzheimers Dement; 2015 Dec; 11(12):1510-1519. PubMed ID: 26079417
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
9. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
10. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults.
Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE
Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848
[TBL] [Abstract][Full Text] [Related]
11. Atrophy is associated with posterior cingulate white matter disruption in dementia with Lewy bodies and Alzheimer's disease.
Firbank MJ; Blamire AM; Krishnan MS; Teodorczuk A; English P; Gholkar A; Harrison R; O'Brien JT
Neuroimage; 2007 May; 36(1):1-7. PubMed ID: 17412610
[TBL] [Abstract][Full Text] [Related]
12. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
[TBL] [Abstract][Full Text] [Related]
13. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
[TBL] [Abstract][Full Text] [Related]
15. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
[TBL] [Abstract][Full Text] [Related]
16. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.
Brickman AM; Provenzano FA; Muraskin J; Manly JJ; Blum S; Apa Z; Stern Y; Brown TR; Luchsinger JA; Mayeux R
Arch Neurol; 2012 Dec; 69(12):1621-7. PubMed ID: 22945686
[TBL] [Abstract][Full Text] [Related]
17. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
18. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.
Huynh K; Piguet O; Kwok J; Dobson-Stone C; Halliday GM; Hodges JR; Landin-Romero R
Neurology; 2021 Mar; 96(13):e1743-e1754. PubMed ID: 33597290
[TBL] [Abstract][Full Text] [Related]
20. Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia.
Pham NTT; Graff-Radford J; Machulda MM; Spychalla AJ; Schwarz CG; Senjem ML; Lowe VJ; Vemuri P; Kantarci K; Knopman DS; Petersen RC; Jack CR; Josephs KA; Whitwell JL
Neurobiol Aging; 2022 Nov; 119():46-55. PubMed ID: 35970009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
